
Keywords: بررسی نتایج فابری; α-Gal A; alpha-galactosidase A; CKD EPI; Chronic Kidney Disease Epidemiology Collaboration; eGFR; estimated glomerular filtration rate; ERT; enzyme replacement therapy; FOS; Fabry Outcome Survey; LVH; left ventricular hypertrophy; LVMI; left ventricular